V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210037781 | 210019270 | null | null | Curative (C) | null | 2017-04-24 | FCR Oral - Cycle 2 onwards | N | N | 210014839 | FCR |
| 210037782 | 210019310 | 1.59 | 10.2 | Disease modification (D) | 2014-02-06 | 2014-05-16 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210015114 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210037783 | 210008318 | 1.79 | 93 | Curative (C) | 2015-06-23 | 2016-04-30 | ALL UKALL60+ TRIAL | N | N | 210015206 | UKALL60+ |
| 210037784 | 210008324 | 0 | 48 | Curative (C) | 2017-03-15 | 2017-03-22 | Triple / Double Intrathecal Therapy | 1 | N | 210015216 | TRIPLE INTRATHECAL |
| 210037785 | 210008340 | 1.52 | 52.5 | Disease modification (D) | 2014-12-10 | 2015-07-22 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | 210015224 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210037786 | 210008383 | 1.69 | 80 | null | 2016-01-24 | 2017-05-23 | CHLORAMBUCIL + OBINUTUZUMAB | 01 | N | 210015310 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210037787 | 210008534 | 1.29 | null | Curative (C) | 2017-08-17 | 2018-06-26 | ALL UKALL60+ TRIAL | Y | null | 210015631 | UKALL60+ |
| 210037788 | 210008545 | 1.54 | 76.3 | Curative (C) | null | 2018-01-08 | ALL UKALL2003 TRIAL | N | N | 210015677 | UKALL 2003 |
| 210037789 | 210008558 | 1.67 | 47.8 | Curative (C) | 2017-05-08 | 2018-02-20 | ALL UKALL2003 TRIAL | N | N | 210015705 | UKALL 2003 |
| 210037790 | 210008564 | 1.75 | 60 | Curative (C) | 2017-10-08 | 2018-05-14 | ALL UKALL2003 TRIAL | Y | N | 210015709 | UKALL 2003 |
| 210037791 | 210008596 | 1.63 | 72 | Palliative (P) | 2018-06-04 | 2018-08-17 | CHLORAMBUCIL + RITUXIMAB | Y | N | 210015782 | CHLORAMBUCIL + RITUXIMAB |
| 210037792 | 210019436 | null | null | Not known (9) | 2017-08-05 | 2017-08-06 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210015788 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210037793 | 210008615 | 1.74 | 95 | Disease modification (D) | 2016-10-08 | 2017-04-22 | Triple Intrathecal | N | N | 210015816 | TRIPLE INTRATHECAL |
| 210037794 | 210008644 | 1.75 | 51.4 | Curative (C) | 2015-11-26 | 2015-11-26 | METHOTREXATE | N | N | 210015905 | METHOTREXATE |
| 210037795 | 210008657 | 1.87 | 63.5 | Curative (C) | 2017-05-02 | 2017-05-02 | ALL UKALL2003 TRIAL | N | N | 210015978 | UKALL 2003 |
| 210037796 | 210019493 | 1.69 | 64.8 | Curative (C) | null | 2016-01-30 | ALL UKALL60+ TRIAL | 02 | N | 210016143 | UKALL60+ |
| 210037798 | 210008732 | 0 | 61.7 | Disease modification (D) | 2018-10-19 | 2018-10-23 | Blinatumomab | Y | Y | 210016258 | BLINATUMOMAB |
| 210037799 | 210008749 | null | null | Curative (C) | 2015-01-05 | 2015-04-24 | MERCAPTOPURINE + METHOTREXATE | N | N | 210016287 | MERCAPTOPURINE + METHOTREXATE |
| 210037800 | 210008766 | 1.73 | null | Curative (C) | 2017-10-02 | 2017-10-08 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | N | N | 210016332 | UKALLR3 |
| 210037801 | 210008922 | null | 63 | Palliative (P) | null | 2018-11-07 | Etoposide Conditioning | Y | N | 210016939 | ETOPOSIDE |
| 210037802 | 210008945 | 1.64 | null | Curative (C) | 2015-03-30 | 2015-03-30 | ETOPOSIDE | N | N | 210017034 | ETOPOSIDE |
| 210037803 | 210008974 | 0 | 53.4 | Curative (C) | 2018-11-13 | 2019-01-25 | Chlorambucil | Y | N | 210017129 | CHLORAMBUCIL |
| 210037804 | 210033244 | 1.85 | 64.2 | null | 2015-05-19 | 2015-06-08 | Etoposide oral | N | N | 210017201 | ETOPOSIDE |
| 210037805 | 210019714 | 1.93 | null | Curative (C) | 2016-12-07 | 2017-07-05 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 210017421 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210037806 | 210019717 | 1.69 | 69.1 | Curative (C) | 2017-02-27 | 2017-07-19 | Alemtuzumab (Subcutaneous) | N | N | 210017422 | ALEMTUZUMAB |
| 210037807 | 210009118 | 1.55 | 65.6 | Curative (C) | null | 2015-11-02 | CHOP R | Y | N | 210017673 | CHOP R |
| 210037808 | 210009225 | 1.68 | 80.75 | null | null | 2018-11-27 | ETOPOSIDE | N | Y | 210018080 | ETOPOSIDE |
| 210037809 | 210009283 | 1.68 | 18 | Palliative (P) | 2017-02-13 | 2017-06-17 | Chlorambucil | N | N | 210018278 | CHLORAMBUCIL |
| 210037810 | 210036039 | null | 95 | null | 2019-06-08 | 2019-07-20 | Mercaptopurine | 01 | N | 210018384 | MERCAPTOPURINE |
| 210037811 | 210030811 | 1.56 | 77.7 | Curative (C) | 2017-12-23 | 2018-08-08 | MERCAPTOPURINE + METHOTREXATE | 01 | N | 210018518 | MERCAPTOPURINE + METHOTREXATE |
| 210037812 | 210009397 | null | 43.9 | Curative (C) | 2017-10-14 | 2017-10-14 | Carboplatin AUC 6 - 10 | 01 | N | 210018579 | CARBOPLATIN |
| 210037813 | 210009436 | 1.69 | 75 | Curative (C) | 2017-12-28 | 2017-12-28 | Carboplatin AUC 2 - 5 | 01 | N | 210018723 | CARBOPLATIN |
| 210037815 | 210020184 | 1.55 | null | Curative (C) | 2017-12-04 | 2017-12-04 | ALL Int GdeC EscCapMaint PhIII PAsp | null | null | 210019691 | ALL INTENSIFICATION |
| 210037816 | 210010191 | null | 88 | Palliative (P) | 2019-09-22 | 2019-09-23 | Mercaptopurine | N | N | 210021334 | MERCAPTOPURINE |
| 210037817 | 210010255 | 1.67 | null | Curative (C) | 2015-05-31 | 2015-06-22 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 210021606 | ALEMTUZUMAB |
| 210037818 | 210010304 | 1.67 | null | Palliative (P) | 2016-08-29 | 2016-09-12 | Venetoclax | N | N | 210021830 | VENETOCLAX |
| 210037819 | 210010464 | 1.62 | 95.8 | Disease modification (D) | 2018-08-08 | 2019-06-23 | Venetoclax | 01 | N | 210023222 | VENETOCLAX |
| 210037820 | 210010495 | 1.64 | 90 | Disease modification (D) | 2018-04-05 | 2018-04-05 | MERCAPTOPURINE + METHOTREXATE | 2 | N | 210023423 | MERCAPTOPURINE + METHOTREXATE |
| 210037821 | 210010697 | 1.65 | 82 | Palliative (P) | 2016-10-02 | 2016-10-02 | Etoposide oral | N | N | 210025775 | ETOPOSIDE |
| 210037822 | 210021031 | null | null | Disease modification (D) | 2018-05-07 | 2018-08-30 | ALL Int Gde A/B DInt PhIV pt1 PAsp | N | null | 210027027 | ALL INTENSIFICATION |
| 210037823 | 210010804 | null | 68.3 | Adjuvant (A) | 2016-01-29 | 2016-11-24 | Alemtuzumab | 2 | N | 210027036 | ALEMTUZUMAB |
| 210037824 | 210010853 | null | 65 | Curative (C) | 2015-03-04 | 2015-08-28 | ALL ALLR3 FLAD Phase IV | N | N | 210027335 | UKALLR3 |
| 210037825 | 210010867 | 1.7 | 53.4 | Curative (C) | 2020-03-17 | 2020-03-20 | Inotuzumab Ozogamicin | N | N | 210027506 | BEVACIZUMAB |
| 210037826 | 210010875 | 1.78 | 80.8 | Curative (C) | 2017-01-27 | 2017-09-23 | Cyclophosphamide oral | N | null | 210027529 | CYCLOPHOSPHAMIDE |
| 210037827 | 210011303 | 1.77 | 87.9 | Curative (C) | 2016-09-24 | 2016-11-12 | CHLORAMBUCIL + OFATUMUMAB | N | N | 210029102 | METHOTREXATE HIGH DOSE |
| 210037828 | 210011366 | 1.8 | 74.2 | Adjuvant (A) | 2018-02-12 | 2018-10-27 | Procarbazine | N | N | 210029291 | PROCARBAZINE |
| 210037829 | 210011734 | null | 77.6 | Curative (C) | 2017-11-30 | 2017-12-03 | IDELALISIB | N | null | 210031025 | INOTUZUMAB OZOGAMICIN |
| 210037830 | 210011828 | 0 | null | Palliative (P) | 2018-11-12 | 2018-11-16 | PONATINIB | N | null | 210031507 | CARBOPLATIN + ETOPOSIDE |
| 210037831 | 210021593 | 1.63 | null | Palliative (P) | 2017-05-13 | 2017-05-15 | Cyclophosphamide TBI Allograft | N | N | 210032019 | CYCLOPHOSPHAMIDE |
| 210037832 | 210031206 | 1.58 | 13.4 | Curative (C) | 2012-09-13 | 2014-08-09 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 210032021 | CARBOPLATIN + VINCRISTINE |